Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Personalized Translational Platform for Biomarker Discovery in Brain Tumors

This study has been completed.
Society of Nuclear Medicine and Molecular Imaging
General Electric
Information provided by (Responsible Party):
Marcelo F. Di Carli, MD, FACC, Brigham and Women's Hospital Identifier:
First received: November 10, 2010
Last updated: August 16, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)